Aidapak Recalls GuaiFENesin ER Tablets Due to Labeling Mixup
Aidapak Services, LLC is recalling guaiFENesin ER tablets because they may be mislabeled as prenatal multivitamin or other medications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup, which fits the rubric for moderate severity involving minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling guaiFENesin ER tablets, 600 mg, because the product may be potentially mislabeled. The recall involves tablets that could be incorrectly identified as PRENATAL MULTIVITAMIN/MULTIMINERAL, diphenhydrAMINE HCl, or DOCUSATE SODIUM.
The affected product is guaiFENesin ER, Tablet, 600 mg, NDC 6382400834. The source text lists specific pedigree codes and expiration dates for the recalled units, including AD62834_4, AD62834_7, W003514, W003574, W003850, W003931, AD46429_1, and AD73592_1. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication labels and stop using the product if it matches the recalled description. They should contact their healthcare provider or pharmacist for guidance on proper medication management.
The recalled product
- Product
- guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824000834
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 480
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- guaiFENesin ER
- Tablet
- 600 mg has the following codes Pedigree: AD62834_4
- EXP: 5/24/2014
- Pedigree: AD62834_7
- Pedigree: W003514
- EXP: 6/21/2014
- Pedigree: W003574
- EXP: 6/24/2014
- Pedigree: W003850
- EXP: 6/27/2014
- Pedigree: W003931
- EXP: 6/28/2014
- Pedigree: AD46429_1
- EXP: 5/15/2014
- Pedigree: AD73592_1
- EXP: 5/31/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Nabumetone Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Niacin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cyanocobalamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Niacin ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSelenium Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Bumetanide Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29